Quick Answer
GUIDED THERAPEUTICS INC reported Net Income Loss of -$3.20 million for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -32.2% in Net Income Loss from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: -$1.71 million | Q3 2015: -$2.19 million | Q1 2016: $130.0 thousand | Q2 2016: -$1.88 million | Q3 2016: -$211.0 thousand | Q1 2017: -$107.0 thousand | Q2 2017: -$1.07 million | Q3 2017: -$2.37 million | Q1 2018: $1.08 million | Q2 2018: $3.42 million | Q3 2018: -$746.0 thousand | Q1 2019: -$215.0 thousand | Q2 2019: -$2.66 million | Q3 2019: -$126.0 thousand | Q1 2020: $2.73 million | Q2 2020: -$6.77 million | Q3 2020: $1.58 million | Q1 2021: -$517.0 thousand | Q2 2021: -$1.03 million | Q3 2021: $68.0 thousand | Q1 2022: -$507.0 thousand | Q2 2022: -$926.0 thousand | Q3 2022: -$1.10 million | Q1 2023: -$869.0 thousand | Q2 2023: -$1.56 million | Q3 2023: -$677.0 thousand | Q1 2024: -$402.00 | Q2 2024: -$709.0 thousand | Q3 2024: -$654.0 thousand | Q1 2025: -$427.00 | Q2 2025: -$811.0 thousand | Q3 2025: -$742.0 thousand.
- Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Net Income Loss has declined by 12.3%.
- Historical annual values: Fiscal year 2025: -$3.20 million | Fiscal year 2024: -$2.42 million | Fiscal year 2023: -$3.49 million | Fiscal year 2022: -$4.34 million | Fiscal year 2021: -$2.07 million | Fiscal year 2020: -$279.0 thousand | Fiscal year 2019: -$1.92 million | Fiscal year 2018: $1.02 million | Fiscal year 2017: -$10.70 million | Fiscal year 2016: -$3.97 million | Fiscal year 2015: -$6.90 million | Fiscal year 2014: -$9.88 million | Fiscal year 2013: -$7.22 million | Fiscal year 2012: -$4.35 million | Fiscal year 2011: -$6.64 million | Fiscal year 2010: -$2.85 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: